Abstract:Objective To explore the effect of down-regulation of high mobility group box 1 (HMGB1) expression on inflammatory response and epithelial mesenchymal transition (EMT) in the lung tissue of mice with chronic obstructive pulmonary disease (COPD) and its related mechanism. Methods The COPD model was induced by cigarette smoking, and HMGB1 expression in lung tissue of mice was down-regulated by small interfering RNA (siRNA). The mice were divided into negative control group (NC group), COPD group, si-NC intervention COPD group, si-HMGB1 intervention COPD group, and tiotropium bromide intervention COPD group (positive control group). After 4 weeks of cigarette smoking induction, the general condition of mice were observed, and the body mass changes of each group were recorded every week. HE staining was used to observe the pathological changes of lung tissue in each group. The expression of HMGB1 mRNA and protein in lung tissues of mice weredetected by real time quantitative PCR and Western blot analysis. The BALF of mice in each group was collected, and the levels of IL-6, TNF-α, IL-1β and TGF-β1 in BALF were detected by ELISA. The expressions of E-cadherin and α-SMA in lung tissues of mice were observed by immunohistochemical staining. The expression of RAGE, TLR4, TGF-β1 and the phosphorylation of NF-κB p65 in lung tissues were detected by Western blot analysis. Results COPD mouse model induced by cigarette smoking was successfully established. Compared with COPD group, down-regulation of HMGB1 expression in lung tissue significantly improved the general vital signs of mice, promoted the increase of body mass, and improved the pathological damage of lung tissue in mice. Compared with the control group, HMGB1 mRNA and protein expression levels increased significantly in COPD group, COPD combined with si-NC group and COPD combined with tiotropium group, while no significant HMGB1 expression was detected in COPD combined with si-HMGB1 group. Compared with the control group, the secretion levels of IL-6, TNF-α, IL-1β, TGF-β1 in BALF, the expression levels of α-SMA, RAGE, TLR4, TGF-β1 and the phosphorylation level of NF-κB p65 in lung tissues were significantly increased in COPD model group, while the expression level of E-cadherin significantly decreased. Compared with the COPD group or the COPD combined with si-NC group, the changes of the above indexes in the lung tissue of mice in the COPD combined with si-HMGB1 group and the COPD combined with tiotropium group dropped markedly, and no significant difference between the latter two groups was found. Conclusion Downregulation of HMGB1 expression in lung tissue of mice can reduce pulmonary inflammatory response and EMT by inhibiting NF-κB pathway, thus ameliorating the progression of cigarette smoke-induced COPD disease.

Effects of GLI pathogenesis-related 1 gene on lung microbiome of mice exposed to cigarette smoke

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets

Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease

GLIPR1 Protects Against Cigarette Smoke-Induced Airway Inflammation Via PLAU/EGFR Signaling

Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments.

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin

Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality

Integrated Analysis of Human Microarray and Rat Transcriptome Identified New Gene Candidates for COPD Progression in Response to Cigarette Smoking

Active Smoking Induces Aberrations in Digestive Tract Microbiota of Rats

When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties

[Down-regulation of HMGB1 expression ameliorates the progression of COPD in mice by inhibiting inflammatory response and epithelial mesenchymal transition]

Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis

Integration of host gene regulation and oral microbiome reveals the influences of smoking during the development of oral squamous cell carcinoma

Akkermansia muciniphila Ameliorates Lung Injury in Smoke-Induced COPD Mice by IL-17 and Autophagy

Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes

Peripheral blood microbial signatures in current and former smokers

Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis